The National Centre For Asbestos Related Diseases (NCARD)
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
The National Centre for Asbestos Related Diseases is a world-leading centre studying the deadly cancers mesothelioma and lung cancer. Our ongoing Centre of Research Excellence program includes research from the development and genetics of asbestos-related cancers, through to new treatments, novel ways of imaging cancer, and the supportive care of people with these cancers. This program will improve the detection, diagnosis, and treatment of mesothelioma and asbestos-related lung cancer.
Australian Resuscitation Outcomes Consortium [AUS-ROC] CRE
Funder
National Health and Medical Research Council
Funding Amount
$2,668,571.00
Summary
The Australian Resuscitation Outcomes Consortium (Aus-ROC) will be modelled on the highly successful North American Resuscitation Outcomes Consortium. The mission of Aus-ROC will be to conduct clinical trials and observational studies into the emergency management of out-of-hospital cardiopulmonary arrest. Building on our existing collaborative partnerships, our goal is to improve patient outcomes and build the research capacity in prehospital emergency care.
Centre For Research Excellence In Pulmonary Fibrosis
Funder
National Health and Medical Research Council
Funding Amount
$2,498,607.00
Summary
The Centre for Research excellence in Pulmonary Fibrosis (CRE-PF) aims to develop a sustainable nation-wide network, consisting of world recognized experts. The group will enable an integrative approach to solving PF through a layered strategy extending from molecules germane to disease pathogenesis, to human studies. With this approach the CRE-PF will set a new paradigm for synergy between academia, health care, health policy and the public, placing Australia at the forefront of innovation.
The Centre for Research Excellence in Nursing Interventions for Hospitalised Patients will provide evidence to improve the nursing care of a broad range of hospitalised patients who are at risk of complications related to compromised skin integrity and poor pain/anxiety management. Systematic reviews and clinical trials will provide the basis for developing clinical practice guidelines to assist nurses in providing high quality care to the 3.5 million Australians admitted to hospital each year.
The Australian Centre For Translational Breast Cancer Research: From Discovery To Better Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$2,619,075.00
Summary
TransBCR will implement a collaborative multidisciplinary research program to help fast track the clinical translation of promising laboratory discoveries in breast cancer. To overcome existing roadblocks, we will carry out early phase clinical trials of novel anti-breast cancer drugs linked to suitable diagnostic tests that help select the right therapy for individual cancer patients. Our goal is to help inform the swift delivery of cost-effective personalised medicine in breast cancer.
Australasian Cerebral Palsy Clinical Trials Network (AusCP-CTN): Optimising Interventions And Effective Services For Children With Cerebral Palsy
Funder
National Health and Medical Research Council
Funding Amount
$2,499,287.00
Summary
Cerebral Palsy (CP) is common and disability can be progressive so the heathcare burden is immense (0.14% GDP). Our Clinical trials network will improve early detection and develop new interventions to improve physical, cognitive and health outcomes for children with CP and their families. Recruitment from the national CP Register will address clinically important questions and test implementation of effective treatments. New Clinical Practice Guidelines will ensure translation internationally.
Respiratory illness in Aboriginal and Torres Strait Islander children is very common with long term consequences in Indigenous Australians. Thus prevention and/or early treatment potentially change the child’s life trajectory for lung health. Partnering key researchers in Brisbane, Sydney, New Zealand and USA, we will undertake appropriate clinical studies (treatment and preventative) that are most likely to improve lung health outcomes in young Indigenous children. We will focus on increasing p ....Respiratory illness in Aboriginal and Torres Strait Islander children is very common with long term consequences in Indigenous Australians. Thus prevention and/or early treatment potentially change the child’s life trajectory for lung health. Partnering key researchers in Brisbane, Sydney, New Zealand and USA, we will undertake appropriate clinical studies (treatment and preventative) that are most likely to improve lung health outcomes in young Indigenous children. We will focus on increasing participation of Indigenous people and end-users.Read moreRead less
Testing, Translation And Uptake Of Evidence In General Practice: A Systems Approach To Rapid Translation
Funder
National Health and Medical Research Council
Funding Amount
$2,411,050.00
Summary
Testing, Translation & Uptake of Evidence in General Practice: A systems approach. Though General Practice is the frontline of Australia’s health system, new research findings are often ignored by busy GPs, resulting in suboptimal care. We plan to improve this by: A. A network of influential GPs practices to test new research, B. Practice support units who provide GP and patient summaries of new research, C. Active transfer of successful new practices via social media, guidelines, and courses.
National Centre Of Research Excellence To Improve Management Of Peripheral Arterial Disease
Funder
National Health and Medical Research Council
Funding Amount
$2,618,637.00
Summary
Approximately 15% of adults have blockages or weakness of major arteries in the periphery, associated with impaired quality of life and a high mortality. Significant management deficiencies for these problems include limited diagnostic, prognostic and treatment options, as well as poor adoption of evidence based practice. The proposed national centre will bring together a group of experts in the field to instigate a number of initiatives to improve patient management.
Centre Of Research Excellence For Patient Blood Management In Critical Illness And Trauma
Funder
National Health and Medical Research Council
Funding Amount
$2,498,410.00
Summary
Blood transfusion is area of major public interest. In critically ill or major trauma patients it can both be life-saving and dangerous. There is continuing uncertainty about how best to use blood and blood products in such patients. The Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma will undertake vital research to improve our understanding of the effects of transfusion on patient outcomes and how to best manage this vital community resource.